Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Takotsubo Cardiomyopathy | 6 | 2023 | 64 | 1.660 |
Why?
|
Obesity | 10 | 2023 | 1166 | 1.600 |
Why?
|
Pericardium | 5 | 2023 | 35 | 1.500 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 805 | 1.340 |
Why?
|
Cardiomyopathies | 4 | 2023 | 119 | 1.330 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 274 | 1.330 |
Why?
|
Ventricular Remodeling | 4 | 2020 | 79 | 1.120 |
Why?
|
Intra-Abdominal Fat | 2 | 2019 | 33 | 1.080 |
Why?
|
Ventricular Function, Left | 4 | 2020 | 257 | 0.840 |
Why?
|
Blood Vessels | 2 | 2014 | 62 | 0.790 |
Why?
|
Heart Valve Diseases | 3 | 2023 | 88 | 0.790 |
Why?
|
Electrocardiography | 7 | 2022 | 521 | 0.770 |
Why?
|
Adipose Tissue | 5 | 2023 | 283 | 0.760 |
Why?
|
Cardiovascular Diseases | 3 | 2014 | 788 | 0.760 |
Why?
|
Inflammation Mediators | 2 | 2019 | 170 | 0.710 |
Why?
|
Pheochromocytoma | 1 | 2020 | 24 | 0.700 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2020 | 40 | 0.700 |
Why?
|
Atherosclerosis | 3 | 2016 | 146 | 0.680 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 243 | 0.680 |
Why?
|
Lipolysis | 1 | 2020 | 47 | 0.670 |
Why?
|
Heart Failure | 4 | 2018 | 853 | 0.670 |
Why?
|
Echocardiography | 5 | 2023 | 457 | 0.650 |
Why?
|
Adiposity | 2 | 2023 | 74 | 0.630 |
Why?
|
Echocardiography, Doppler | 2 | 2018 | 131 | 0.600 |
Why?
|
Vascular Diseases | 2 | 2016 | 75 | 0.600 |
Why?
|
Insulin | 2 | 2020 | 673 | 0.590 |
Why?
|
Adipocytes | 4 | 2023 | 255 | 0.550 |
Why?
|
Adipose Tissue, Brown | 2 | 2023 | 111 | 0.530 |
Why?
|
Polycystic Kidney, Autosomal Dominant | 1 | 2016 | 6 | 0.520 |
Why?
|
Coronary Vessel Anomalies | 1 | 2016 | 16 | 0.510 |
Why?
|
Methylprednisolone | 1 | 2015 | 32 | 0.500 |
Why?
|
Bradycardia | 1 | 2015 | 32 | 0.490 |
Why?
|
Insulin Resistance | 2 | 2016 | 392 | 0.490 |
Why?
|
Humans | 35 | 2023 | 59366 | 0.490 |
Why?
|
Cardiac Catheterization | 2 | 2016 | 253 | 0.470 |
Why?
|
Aortic Valve Insufficiency | 1 | 2015 | 42 | 0.470 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 211 | 0.450 |
Why?
|
Glucocorticoids | 1 | 2015 | 179 | 0.440 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 107 | 0.440 |
Why?
|
Diastole | 3 | 2023 | 89 | 0.430 |
Why?
|
Lectins, C-Type | 1 | 2013 | 88 | 0.410 |
Why?
|
Inflammation | 4 | 2017 | 1098 | 0.410 |
Why?
|
Myocardial Infarction | 2 | 2017 | 861 | 0.410 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 133 | 0.410 |
Why?
|
Multiple Sclerosis | 1 | 2015 | 207 | 0.410 |
Why?
|
Outpatients | 1 | 2013 | 137 | 0.400 |
Why?
|
Ventricular Premature Complexes | 2 | 2022 | 21 | 0.370 |
Why?
|
Macrophages | 2 | 2016 | 1015 | 0.360 |
Why?
|
Coronary Angiography | 3 | 2019 | 176 | 0.350 |
Why?
|
Biomarkers, Tumor | 1 | 2013 | 461 | 0.340 |
Why?
|
Thinness | 1 | 2009 | 40 | 0.330 |
Why?
|
Thermogenesis | 3 | 2023 | 116 | 0.320 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2020 | 158 | 0.320 |
Why?
|
Heart Failure, Diastolic | 1 | 2009 | 9 | 0.320 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2009 | 47 | 0.310 |
Why?
|
Heart Atria | 3 | 2023 | 135 | 0.290 |
Why?
|
Middle Aged | 13 | 2021 | 16310 | 0.290 |
Why?
|
Diet | 1 | 2011 | 496 | 0.290 |
Why?
|
Male | 17 | 2023 | 27742 | 0.290 |
Why?
|
Stroke Volume | 2 | 2018 | 314 | 0.270 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2019 | 527 | 0.260 |
Why?
|
Female | 17 | 2020 | 30719 | 0.260 |
Why?
|
Body Mass Index | 1 | 2009 | 831 | 0.250 |
Why?
|
Prognosis | 4 | 2018 | 1597 | 0.250 |
Why?
|
Predictive Value of Tests | 2 | 2020 | 1027 | 0.230 |
Why?
|
Systole | 2 | 2015 | 109 | 0.230 |
Why?
|
Aged | 11 | 2020 | 13405 | 0.230 |
Why?
|
Practice Patterns, Physicians' | 1 | 2009 | 692 | 0.220 |
Why?
|
Heart Ventricles | 3 | 2023 | 253 | 0.220 |
Why?
|
Heart Valves | 2 | 2023 | 23 | 0.210 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2023 | 37 | 0.210 |
Why?
|
Glutamine | 1 | 2023 | 46 | 0.210 |
Why?
|
Fibrosis | 1 | 2023 | 153 | 0.200 |
Why?
|
Massachusetts | 4 | 2013 | 2019 | 0.190 |
Why?
|
Animals | 10 | 2023 | 19649 | 0.190 |
Why?
|
Myocardial Ischemia | 2 | 2017 | 111 | 0.190 |
Why?
|
Wearable Electronic Devices | 1 | 2022 | 62 | 0.190 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2021 | 3 | 0.190 |
Why?
|
Infarction, Posterior Cerebral Artery | 1 | 2021 | 7 | 0.190 |
Why?
|
Glucose | 2 | 2023 | 445 | 0.180 |
Why?
|
Atrial Premature Complexes | 1 | 2021 | 13 | 0.180 |
Why?
|
Adrenergic Agents | 1 | 2020 | 15 | 0.180 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2020 | 5 | 0.170 |
Why?
|
Diet, Reducing | 1 | 2020 | 27 | 0.170 |
Why?
|
Uncoupling Protein 1 | 3 | 2020 | 50 | 0.170 |
Why?
|
Hypertension | 1 | 2005 | 568 | 0.160 |
Why?
|
Subcutaneous Fat | 1 | 2019 | 46 | 0.160 |
Why?
|
Oxygen Consumption | 2 | 2020 | 206 | 0.160 |
Why?
|
Muscle, Skeletal | 2 | 2023 | 674 | 0.160 |
Why?
|
Weight Gain | 1 | 2020 | 163 | 0.160 |
Why?
|
Cytokines | 3 | 2017 | 915 | 0.160 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2019 | 294 | 0.150 |
Why?
|
Apolipoproteins E | 2 | 2015 | 108 | 0.150 |
Why?
|
RNA, Long Noncoding | 1 | 2020 | 152 | 0.150 |
Why?
|
Risk Assessment | 3 | 2018 | 1925 | 0.140 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2017 | 90 | 0.140 |
Why?
|
Lectins | 1 | 2017 | 40 | 0.140 |
Why?
|
Adipogenesis | 1 | 2018 | 71 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 62 | 0.140 |
Why?
|
Prevalence | 3 | 2010 | 1253 | 0.140 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 718 | 0.130 |
Why?
|
Risk Factors | 4 | 2018 | 4986 | 0.130 |
Why?
|
Interferon Type I | 1 | 2017 | 169 | 0.130 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 2 | 0.130 |
Why?
|
Stem Cells | 1 | 2018 | 255 | 0.130 |
Why?
|
NADPH Oxidases | 1 | 2015 | 67 | 0.120 |
Why?
|
Mice | 7 | 2023 | 10294 | 0.120 |
Why?
|
Infusions, Intravenous | 1 | 2015 | 163 | 0.120 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2016 | 117 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2016 | 101 | 0.120 |
Why?
|
Aged, 80 and over | 5 | 2020 | 5119 | 0.120 |
Why?
|
Ion Channels | 2 | 2016 | 88 | 0.120 |
Why?
|
Glucose Intolerance | 1 | 2016 | 88 | 0.120 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2016 | 146 | 0.120 |
Why?
|
Time Factors | 3 | 2018 | 3615 | 0.120 |
Why?
|
Mice, Inbred C57BL | 4 | 2018 | 3231 | 0.120 |
Why?
|
Mitochondrial Proteins | 2 | 2016 | 100 | 0.120 |
Why?
|
Brain Ischemia | 1 | 2018 | 399 | 0.120 |
Why?
|
Endothelial Cells | 1 | 2015 | 173 | 0.110 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 205 | 0.110 |
Why?
|
Lipid Metabolism | 1 | 2016 | 203 | 0.110 |
Why?
|
Pancreatitis-Associated Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
Follow-Up Studies | 3 | 2014 | 2338 | 0.110 |
Why?
|
Autophagy | 1 | 2016 | 213 | 0.110 |
Why?
|
Blood Glucose | 1 | 2016 | 461 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2016 | 1465 | 0.110 |
Why?
|
ROC Curve | 1 | 2013 | 267 | 0.100 |
Why?
|
Severity of Illness Index | 2 | 2017 | 1479 | 0.100 |
Why?
|
Treatment Outcome | 2 | 2016 | 5281 | 0.100 |
Why?
|
Cause of Death | 1 | 2013 | 210 | 0.100 |
Why?
|
Algorithms | 3 | 2022 | 974 | 0.100 |
Why?
|
Photoplethysmography | 2 | 2022 | 33 | 0.100 |
Why?
|
Mitochondria, Heart | 1 | 2011 | 13 | 0.090 |
Why?
|
Prospective Studies | 2 | 2021 | 3067 | 0.090 |
Why?
|
Microarray Analysis | 1 | 2011 | 60 | 0.090 |
Why?
|
Survival Rate | 1 | 2013 | 801 | 0.090 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2022 | 96 | 0.090 |
Why?
|
Retrospective Studies | 5 | 2018 | 6069 | 0.090 |
Why?
|
Torsades de Pointes | 1 | 2010 | 6 | 0.090 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 81 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2011 | 133 | 0.090 |
Why?
|
Neutrophil Infiltration | 1 | 2011 | 60 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2010 | 30 | 0.090 |
Why?
|
Heart Rate | 2 | 2022 | 307 | 0.090 |
Why?
|
Dietary Fats | 1 | 2011 | 173 | 0.090 |
Why?
|
Stroke | 1 | 2018 | 1127 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2011 | 644 | 0.080 |
Why?
|
Immunohistochemistry | 1 | 2011 | 847 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 2092 | 0.080 |
Why?
|
Heart Failure, Systolic | 1 | 2009 | 16 | 0.080 |
Why?
|
Cardiotonic Agents | 1 | 2009 | 50 | 0.080 |
Why?
|
Disease Progression | 1 | 2013 | 1119 | 0.070 |
Why?
|
Biomarkers | 1 | 2013 | 1306 | 0.070 |
Why?
|
Acute Disease | 1 | 2009 | 658 | 0.070 |
Why?
|
Odds Ratio | 1 | 2009 | 747 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2009 | 185 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2017 | 1997 | 0.070 |
Why?
|
Ultrasonography | 1 | 2009 | 457 | 0.070 |
Why?
|
Logistic Models | 1 | 2009 | 1235 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 931 | 0.060 |
Why?
|
Aorta | 2 | 2018 | 108 | 0.060 |
Why?
|
Age Factors | 1 | 2009 | 1504 | 0.060 |
Why?
|
Hospital Mortality | 1 | 2009 | 841 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2009 | 442 | 0.060 |
Why?
|
Signal Transduction | 1 | 2014 | 2903 | 0.050 |
Why?
|
Cohort Studies | 1 | 2009 | 2375 | 0.050 |
Why?
|
Artifacts | 1 | 2022 | 125 | 0.050 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 1552 | 0.050 |
Why?
|
Perilipin-1 | 1 | 2020 | 11 | 0.040 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2020 | 56 | 0.040 |
Why?
|
Lipid Droplets | 1 | 2020 | 31 | 0.040 |
Why?
|
Cell Communication | 1 | 2020 | 124 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 153 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2017 | 45 | 0.040 |
Why?
|
Energy Metabolism | 1 | 2020 | 359 | 0.040 |
Why?
|
Disability Evaluation | 1 | 2018 | 199 | 0.040 |
Why?
|
Adipokines | 1 | 2017 | 28 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 39 | 0.040 |
Why?
|
Cell Nucleus | 1 | 2020 | 608 | 0.030 |
Why?
|
Enkephalins | 1 | 2016 | 16 | 0.030 |
Why?
|
Proprotein Convertase 1 | 1 | 2016 | 7 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
Interleukin-33 | 1 | 2016 | 18 | 0.030 |
Why?
|
Iodide Peroxidase | 1 | 2016 | 23 | 0.030 |
Why?
|
Cell Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
Integrin beta1 | 1 | 2016 | 28 | 0.030 |
Why?
|
Capillaries | 1 | 2016 | 30 | 0.030 |
Why?
|
United States | 1 | 2009 | 7426 | 0.030 |
Why?
|
Glucose Clamp Technique | 1 | 2016 | 57 | 0.030 |
Why?
|
Receptors, LDL | 1 | 2015 | 33 | 0.030 |
Why?
|
Adipocytes, White | 1 | 2016 | 27 | 0.030 |
Why?
|
Aminopyridines | 1 | 2015 | 31 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 96 | 0.030 |
Why?
|
Protein Precursors | 1 | 2016 | 75 | 0.030 |
Why?
|
NADPH Oxidase 4 | 1 | 2015 | 6 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 217 | 0.030 |
Why?
|
Aortic Valve | 1 | 2017 | 173 | 0.030 |
Why?
|
Transcription Factors | 1 | 2023 | 1471 | 0.030 |
Why?
|
Adipocytes, Brown | 1 | 2016 | 45 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 107 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2016 | 163 | 0.030 |
Why?
|
Transcriptome | 1 | 2018 | 340 | 0.030 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2015 | 191 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2016 | 495 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 169 | 0.030 |
Why?
|
Blotting, Western | 1 | 2015 | 583 | 0.030 |
Why?
|
Phenotype | 1 | 2018 | 1137 | 0.030 |
Why?
|
NF-kappa B | 1 | 2015 | 460 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2015 | 279 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 635 | 0.030 |
Why?
|
Homeostasis | 1 | 2016 | 346 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2015 | 207 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2015 | 551 | 0.030 |
Why?
|
Mice, Transgenic | 1 | 2015 | 1206 | 0.020 |
Why?
|
Adult | 2 | 2020 | 15679 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2015 | 941 | 0.020 |
Why?
|
Young Adult | 1 | 2020 | 4273 | 0.020 |
Why?
|
Proteins | 1 | 2016 | 730 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 1151 | 0.020 |
Why?
|